Intestinal metaplasia in Barrett's oesophagus: An essential factor to predict the risk of dysplasia and cancer development

Dig Liver Dis. 2016 Feb;48(2):144-7. doi: 10.1016/j.dld.2015.10.021. Epub 2015 Nov 11.

Abstract

Background: To date, there is still uncertainty on the role of specialized intestinal metaplasia in the carcinogenic process of Barrett's oesophagus (BE); this fact seems of importance for planning adequate surveillance programs.

Aims: To predict the risk of progression towards dysplasia/cancer based on typical morphological features by evaluating the importance of intestinal metaplasia in BE patients.

Methods: 647 cases with a histological diagnosis of BE, referred to the Endoscopy Unit of a tertiary centre between 2000 and 2012 were retrospectively identified, and divided into two groups according to the presence/absence of intestinal metaplasia. For each patient, all histological reports performed during a follow-up of 4-8 years were analyzed.

Results: Overall, 537 cases (83%) with intestinal metaplasia and 110 cases (17%) without intestinal metaplasia were included. During the follow-up period, none of the patients without intestinal metaplasia developed dysplasia/cancer nor progressed to metaplasia, whereas 72 patients with intestinal metaplasia (13.4%) showed histological progression of the disease.

Conclusion: The histological identification of intestinal metaplasia seems to be an essential factor for the progression towards dysplasia and cancer in BE patients.

Keywords: Barrett's oesophagus; Cancer development; Endoscopy; Intestinal metaplasia.

MeSH terms

  • Adenocarcinoma / epidemiology*
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Barrett Esophagus / pathology*
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Disease Progression
  • Esophageal Neoplasms / epidemiology*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Metaplasia
  • Middle Aged
  • Precancerous Conditions / epidemiology*
  • Retrospective Studies
  • Risk
  • Young Adult